Hope Is on the Way: Improving Therapy for Nonalcoholic Steatohepatitis

Hope Is on the Way: Improving Therapy for Nonalcoholic Steatohepatitis is organized by AchieveCE.

Release Date: 06/16/2021
Expiration Date: 07/31/2027

Activity Overview:
Many clinicians are not fully aware of the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH. Furthermore, several clinicians are not fully aware of optimal treatment strategies in patients with NAFLD and NASH. Additionally, many healthcare professionals are unfamiliar with the clinical data on the efficacy of investigational therapies for NASH. This activity aims to describe for healthcare professionals the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH, summarize treatment strategies in patients with NAFLD and NASH, and examine the results of clinical studies about the medications for NASH patients.

Pharmacist Learning Objectives:

• Discuss the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH
• Summarize treatment options in patients with NAFLD and NASH
• Examine efficacy data emerging from clinical studies of medications to treat NASH

Pharmacy Technician Learning Objectives:

• Recall how noninvasive tools and biomarkers can be applied in patients with NAFLD and NASH
• List treatment options in patients with NAFLD and NASH
• Review the literature of medications to treat NASH

Nurse Learning Objectives:

• Discuss the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH
• List treatment options in patients with NAFLD and NASH
• Review the literature of medications to treat NASH